Literature DB >> 1992770

Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.

C C van Niekerk1, O C Boerman, F C Ramaekers, L G Poels.   

Abstract

To investigate whether early changes in the transformation of normal ovarian epithelial cells into tumor cells can be detected with monoclonal antibodies, a comparative immunohistochemical study was performed on normal human ovarian mesothelial cells, cystomas, cystadenomas, ovarian carcinomas, as well as granulosa cell tumor. Using monoclonal antibodies against different keratin subtypes, it was shown that mesothelial cells, ovarian cysts, cystadenomas, and carcinomas all reacted positively with broad-spectrum anti-keratin monoclonal antibodies (MAbs), as well as with MAbs to keratins 7, 8, 18, and 19. Keratins 4 and 13 were not found in mesothelial cells, but positive groups of cells were identified in several cystomas, adenomas, and carcinomas. While mesothelial cells did not react with the pan-epithelial marker BW495/36, invaginating metaplastic mesothelial cells, inclusion cysts, cystomas, adenomas, and carcinomas showed an increasing reactivity with BW495/36, with an increasing degree of malignancy. The reactivity of MAbs against ovarian carcinoma-associated antigens (OV-TL 3, OC 125, MOv 18, and OV-TL 10) was limited to weak staining reaction in some mesothelial cells but were found to be positive on more than 50% of the ovarian cystadenomas and more than 90% of the ovarian carcinomas. Thecal and granulosa cells of primordial, primary, and secondary follicles all reacted positively with antibodies to the broad-spectrum keratins OV-TL 12/5 and RCK 102, and to keratins 8 and 18, but not with keratins 4, 7, 13, and 19. These keratins decreased or disappeared in granulosa cells of mature follicles (Graafian follicles), whereas granulosa cell tumors did not react with anti-keratin antibodies. The reactivity of BW 495/36 was negative or limited to traces in some granulosa cells. Ovarian carcinoma-associated antigens were not expressed in granulosa cells or granulosa cell tumors. The data indicate that mesothelial cells undergoing metaplastic changes finally resulting in ovarian cystadenomas (and carcinomas) initiate the synthesis of a 200-kd glycoprotein recognized by MAb (BW 495/36), the production of ovarian carcinoma associated antigens, in addition to focal production of keratin 4 and/or 13, as seen in several samples. The granulosa cell tumors decrease or switch off their keratin production and remain negative for the 200-kd glycoprotein and the ovarian carcinoma-associated antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992770      PMCID: PMC1886195     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Changing intermediate-sized filament patterns in metastatic hepatocellular carcinoma cells of the guinea pig.

Authors:  F van de Molengraft; F Ramaekers; P Jap; P Vooijs; G Mungyer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

2.  Regulation of cytoskeletal protein organization and expression in human granulosa cells in response to gonadotropin treatment.

Authors:  A Ben-Ze'ev; A Amsterdam
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

3.  Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins.

Authors:  P C Stasiak; P E Purkis; I M Leigh; E B Lane
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

4.  Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.

Authors:  F Ramaekers; C van Niekerk; L Poels; E Schaafsma; A Huijsmans; H Robben; G Schaart; P Vooijs
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia.

Authors:  F Smedts; F Ramaekers; H Robben; M Pruszczynski; G van Muijen; B Lane; I Leigh; P Vooijs
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.

Authors:  E J Nouwen; P G Hendrix; S Dauwe; M W Eerdekens; M E De Broe
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

7.  Monoclonal antibody against human ovarian tumor-associated antigens.

Authors:  L G Poels; D Peters; Y van Megen; G P Vooijs; R N Verheyen; A Willemen; C C van Niekerk; P H Jap; G Mungyer; P Kenemans
Journal:  J Natl Cancer Inst       Date:  1986-05       Impact factor: 13.506

8.  Carcinoembryonic antigen localization in benign and malignant transitional epithelium.

Authors:  M M Shevchuk; C M Fenoglio; R M Richart
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

9.  Tissue distribution of keratin 7 as monitored by a monoclonal antibody.

Authors:  F Ramaekers; A Huysmans; G Schaart; O Moesker; P Vooijs
Journal:  Exp Cell Res       Date:  1987-05       Impact factor: 3.905

10.  Marker profile of mesothelial cells versus ovarian carcinoma cells.

Authors:  C C van Niekerk; P H Jap; C M Thomas; D F Smeets; F C Ramaekers; L G Poels
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

View more
  9 in total

1.  Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary.

Authors:  D Santini; C Ceccarelli; G Mazzoleni; G Pasquinelli; V M Jasonni; G N Martinelli
Journal:  Histochemistry       Date:  1993-04

2.  Presence of the intermediate filaments cytokeratins and vimentin in the rat corpus luteum during luteal life-span.

Authors:  I Nilsson; M O Mattsson; G Selstam
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

3.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

4.  Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma.

Authors:  Igor But
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

5.  Changes in expression of differentiation markers between normal ovarian cells and derived tumors.

Authors:  C C Van Niekerk; F C Ramaekers; A G Hanselaar; J Aldeweireldt; L G Poels
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

6.  Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.

Authors:  O Gubbay; W Guo; M T Rae; D Niven; S P Langdon; S G Hillier
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

7.  External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.

Authors:  Hans Reinauer; William Graham Wood
Journal:  Ger Med Sci       Date:  2005-05-30

8.  Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.

Authors:  E C Abeln; W E Corver; N J Kuipers-Dijkshoorn; G J Fleuren; C J Cornelisse
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

9.  Linking the ovarian cancer transcriptome and immunome.

Authors:  Ronald Rapberger; Paul Perco; Cornelia Sax; Thomas Pangerl; Christian Siehs; Dietmar Pils; Andreas Bernthaler; Arno Lukas; Bernd Mayer; Michael Krainer
Journal:  BMC Syst Biol       Date:  2008-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.